https://www.selleckchem.com/pr....oducts/relacorilant.
Moreover, there was no significant difference in the frequency of severe COVID-19 infection between ABO blood types (O 50%, A 53%, B 56%, AB 57%; P=0.93), or any additional outcomes including in-hospital mortality rate (P=0.72), need for ICU admission (P=0.66), ICU free days at day 28 (P=0.51), hospital free days at day 28 (P=0.43), or need for acute renal replacement therapy (P=0.09). We did not find an increased susceptibility of any blood type to COVID-19 infection, nor was there an increased risk of severe COVID-19 infection in
Like
Comment
Share
